Dry Eye and Microenvironment
Dry Eye and Microenvironment
批准号:
9176495
负责人:
Anat Galor
金额:
$38.03万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-08-31
关键词:
AddressAffectAgeAir PollutantsAir PollutionAllergensAmericanAntioxidantsAreaCellular PhoneCharacteristicsCitiesClimateClinicClinicalClinical assessmentsComorbidityComplex MixturesDataDevelopmentDietDiseaseDrynessEconometric ModelsEnvironmental Risk FactorEpithelialEpitheliumEthnic OriginExclusion CriteriaExposure toEyeEye InfectionsFatty AcidsFrequenciesGasesGenderGoalsHome environmentHormonal ChangeHumidityImmunologyIndividualIndoor Air PollutionIndoor environmentInflammationInstitutesInternetInterventionKnowledgeLife StyleLightLiteratureLocationMarylandMeasurementMeasuresModelingMonitorMorbidity - disease rateNational Eye InstituteOphthalmologyPainParticipantParticulate MatterPatientsPatternPlant RootsProductionPublic HealthPublishingQuality of lifeRaceReadingRecruitment ActivityRedwoodReportingResearchRoleSeasonsSeveritiesSigns and SymptomsSmokingSourceSwimmingSymptomsTemperatureTestingTimeUniversitiesVisionVisitWaterWeightWorkambient air pollutionbasecase controlcost effectivedesignenvironmental interventionevaporationeye drynessfood consumptionhormone therapyimprovedinclusion criteriaindoor exposurelaboratory facilitymeetingsnovelocular painpersistent symptompollutantpreventprospectivepublic health relevancereduce symptomssensorspatiotemporalvolatile organic compound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Dry eye (DE), characterized by a myriad of signs (e.g. decreased tear production,
increased evaporation, and inflammation) and symptoms (e.g. pain, blurry vision and dryness), is a debilitating
disease that affects quality of life. Many patients have persistent symptoms, because the available clinical
therapies are not adequate to manage DE. Thus, managing DE requires solutions (i.e. beyond individual-
level clinical interventions). An emerging literature suggests that environmental conditions can contribute to the
onset and persistence of DE. Our microenvironment is a complex mixture of particulate matter (PM), gaseous
air pollutants and allergens. However, individual specific data on microenvironment are not available. The
project will test two novel hypotheses: 1) the clinical manifestations, measured by the types and severity
of different measures of DE, vary with respect to types, levels and sources of air pollutants, allergens,
humidity and temperature, specifically, exposure to PM, bioaerosols and gaseous pollutants is associated
with epithelial disruption (ED), inflammation and evaporative tear deficiency (ETD), respectively; 2) DE signs
are more strongly associated with indoor relative to outdoor air pollution, as we spend more time indoors
and our indoor exposure dominates our total exposure to microenvironmental conditions. To test these
hypotheses, we propose a prospective case-control design. We will recruit 360 subjects from Bascom
Palmer Eye Institute (BPEI), ranked as the number 1 eye institute in the US consecutively for the past 12
years, and University of Maryland Ophthalmology – Redwood (UMOR) clinics. 180 cases and age-,
gender- and race/ethnicity-matched 180 controls will be determined after their clinical exams. Subjects who
meet the inclusion criteria and have at least one of the three measures of DE, namely ED, inflammation, and
ETD, will serve as cases, and controls will be free from these DE signs, and will meet inclusion criteria. Each
subject will undergo four clinical exams one in each of the four seasons, and a weeklong intensive air pollution
monitoring inside and outside their homes before the clinical exam. PRECISE (precise.ccs.miami.edu), our
portable battery of direct-reading sensors, will measure air pollution in each subject's home for one full year.
Over the same week, participants will record DE symptoms through web or phone. We will calculate time-
weighted indoor and outdoor exposures, and model the effects of exposure on DE signs and symptoms using
spatial econometric models. Our interdisciplinary team has the state-of-the-art laboratory facilities for clinical
assessment of DE and exposure assessment as well as a collaborative track-record over four years. This
project will generate knowledge that will potentially provide a new line of home-based environmental treatment
to manage DE. This research aligns with the “ocular infection, inflammation and immunology” priority
areas of the National Eye Institute (NEI).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining bacterial members of the ocular surface microbiome and assessing stability over time
-
批准号:10668753
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2023
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10013711
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Neural mechanisms underlying photophobia and dry eye
-
批准号:10704725
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Neural mechanisms underlying photophobia and dry eye
-
批准号:10425233
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10293544
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Neural mechanisms underlying photophobia and dry eye
-
批准号:9885368
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10514592
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:9325036
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:10011823
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:9767193
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
海外基金